These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37329450)

  • 61. Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.
    Niechciał E; Rogowicz-Frontczak A; Piłaciński S; Fichna M; Skowrońska B; Fichna P; Zozulińska-Ziółkiewicz D
    Acta Diabetol; 2018 Mar; 55(3):287-294. PubMed ID: 29327148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation.
    Eason RJ; Thomas NJ; Hill AV; Knight BA; Carr A; Hattersley AT; McDonald TJ; Shields BM; Jones AG;
    Diabetes Care; 2022 Dec; 45(12):2844-2851. PubMed ID: 36205650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study.
    Boboc AA; Novac CN; Marin AG; Ieșanu MI; Plătică C; Buzescu T; Coșoreanu MT; Galoș F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado.
    McQueen RB; Geno Rasmussen C; Waugh K; Frohnert BI; Steck AK; Yu L; Baxter J; Rewers M
    Diabetes Care; 2020 Jul; 43(7):1496-1503. PubMed ID: 32327420
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ketoacidosis in new-onset type 1 diabetes: did the severity increase during the COVID-19 pandemic?
    Botelho TA; Santos JMN; Pinho CMS; Martins AIBR; Formiga AIS; Serra-Caetano J; Cardoso RCF; Dinis ICAD; Mirante ASR
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):73-77. PubMed ID: 34766743
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in the presentation of newly diagnosed type 1 diabetes in children during the COVID-19 pandemic in a tertiary center in Southern Turkey.
    Dilek SÖ; Gürbüz F; Turan İ; Celiloğlu C; Yüksel B
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1303-1309. PubMed ID: 34291625
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glycated hemoglobin at diagnosis of type 1 diabetes and at follow-up in children and adolescents during the COVID-19 pandemic in Germany.
    Kamrath C; Rosenbauer J; Eckert AJ; Ohlenschläger U; Sydlik C; Nellen-Hellmuth N; Holl RW
    Pediatr Diabetes; 2022 Sep; 23(6):749-753. PubMed ID: 35366047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.
    Humphreys A; Bravis V; Kaur A; Walkey HC; Godsland IF; Misra S; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2019 Sep; 155():107789. PubMed ID: 31326456
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk.
    Schlosser M; Koczwara K; Kenk H; Strebelow M; Rjasanowski I; Wassmuth R; Achenbach P; Ziegler AG; Bonifacio E
    Diabetologia; 2005 Sep; 48(9):1830-2. PubMed ID: 16010521
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes.
    Alonso GT; Ebekozien O; Gallagher MP; Rompicherla S; Lyons SK; Choudhary A; Majidi S; Pinnaro CT; Balachandar S; Gangat M; Curda Roberts AJ; Marks BE; Creo A; Sanchez J; Seeherunvong T; Jimenez-Vega J; Patel NS; Wood JR; Gabriel L; Sumpter KM; Wilkes M; Rapaport R; Cymbaluk A; Wong JC; Sanda S; Albanese-O'neill A
    J Diabetes; 2021 Aug; 13(8):681-687. PubMed ID: 33855813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characteristics of adult- compared to childhood-onset type 1 diabetes.
    Casu A; Kanapka LG; Foster NC; Hirsch IB; Laffel LM; Shah VN; DeSalvo DJ; Lyons SK; Vendrame F; Aleppo G; Mastrandrea LD; Pratley RE; Rickels MR; Peters AL;
    Diabet Med; 2020 Dec; 37(12):2109-2115. PubMed ID: 32353892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes.
    Kallas-Koeman MM; Kong JM; Klinke JA; Butalia S; Lodha AK; Lim KI; Duan QM; Donovan LE
    Diabetologia; 2014 Apr; 57(4):681-9. PubMed ID: 24434960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Silent Epidemic of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and Adolescents in Italy During the COVID-19 Pandemic in 2020.
    Cherubini V; Marino M; Scaramuzza AE; Tiberi V; Bobbio A; Delvecchio M; Piccinno E; Ortolani F; Innaurato S; Felappi B; Gallo F; Ripoli C; Ricciardi MR; Pascarella F; Stamati FA; Citriniti F; Arnaldi C; Monti S; Graziani V; De Berardinis F; Giannini C; Chiarelli F; Zampolli M; De Marco R; Bracciolini GP; Grosso C; De Donno V; Piccini B; Toni S; Coccioli S; Cardinale G; Bassi M; Minuto N; D'Annunzio G; Maffeis C; Marigliano M; Zanfardino A; Iafusco D; Rollato AS; Piscopo A; Curto S; Lombardo F; Bombaci B; Sordelli S; Mameli C; Macedoni M; Rigamonti A; Bonfanti R; Frontino G; Predieri B; Bruzzi P; Mozzillo E; Rosanio F; Franzese A; Piredda G; Cardella F; Iovane B; Calcaterra V; Berioli MG; Lasagni A; Pampanini V; Patera PI; Schiaffini R; Rutigliano I; Meloni G; De Sanctis L; Tinti D; Trada M; Guerraggio LP; Franceschi R; Cauvin V; Tornese G; Franco F; Musolino G; Maltoni G; Talarico V; Iannilli A; Lenzi L; Matteoli MC; Pozzi E; Moretti C; Zucchini S; Rabbone I; Gesuita R
    Front Endocrinol (Lausanne); 2022; 13():878634. PubMed ID: 35784550
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
    de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
    Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study.
    Kordonouri O; Danne T; Enders I; Weber B
    Eur J Pediatr; 1998 Mar; 157(3):202-7. PubMed ID: 9537486
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.